Elevated serum concentration of human IL-10 has been put forward as a marker for detection of early PTLD development [120, 121] and a combination of 2 SNPs in its promoter region was associated with increased risk for development of B-cell lymphoma [122]. The gene discussed is IL10; the disease is post-transplant lymphoproliferative disease.